NED Davis Research 360 Dynamic Allocation Etf(NDAA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NDAA NED Davis Research 360 Dynamic Allocation Etf

交易中 08-24 10:28:16 EDT

24.43

+0.00

0.00%

最高24.43	最低24.43	成交量17.00
今开24.43	昨收24.43	日振幅0.00%
总市值1.76亿	流通市值1.76亿	总股本718.43万
成交额413.99	换手率0.00%	流通股本718.43万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NDAA","market":"US","secType":"STK","nameCN":"NED Davis Research 360 Dynamic Allocation Etf","latestPrice":24.4283,"timestamp":1787581428962,"preClose":24.4283,"halted":0,"volume":17,"delay":0,"changeRate":0,"floatShares":7184338,"shares":7184338,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"08-24 10:28:16 EDT","open":24.4283,"high":24.4283,"low":24.4283,"amount":413.99161599999996,"amplitude":0,"askPrice":24.37,"askSize":2000,"bidPrice":24.3,"bidSize":2000,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":24.4283,"sharesOutstanding":130000,"nav":24.28,"aum":174435653.8,"dividendRate":0.02407,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":24.3119,"preClose":24.4283,"latestTime":"16:04 EDT","volume":2,"amount":48.8566,"timestamp":1787342648366,"change":-0.1164,"changeRate":-0.004765,"amplitude":0},"volumeRatio":0.176244},"requestUrl":"/m/hq/s/NDAA","defaultTab":"news","newsList":[{"id":"2660105476","title":"全球资产配置进入“去拥挤化”时刻！美银从AI算力转向价值、生物科技与大宗商品","url":"https://stock-news.laohu8.com/highlight/detail?id=2660105476","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660105476?lang=zh_cn&edition=full","pubTime":"2026-08-17 09:15","pubTimestamp":1786929314,"startTime":"0","endTime":"0","summary":"不过，该行警告称，从长期来看，最大规模的增量收益可能最终流向消费者和全球整体经济，而不是那些为大规模建设AI算力基础设施提供支持的科技企业。因此，美国银行转而看好大宗商品和其他实物资产。","market":"us","thumbnail":"https://static.tigerbbs.com/55eb327f580527889cf30bafa92692ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/55eb327f580527889cf30bafa92692ae"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480529.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GAL","UDOW","NJUL","AGNG","SDS","KOOL","SPUU","UPRO","SYNB","IVV","QQQX","HIBL","NMBL","BTR","EEV","NAPR","SPYH","SPY","AGOX","PSQ","QID","GMOM","03086","AVMA","QDEC","02834",".IXIC","SSO","TCTL","GDMA","FPAA","SPXL","SPYM","DDX","DRAI","DOG","QLD","SMAX","07568","BK4581","ITDF","IBBJ","IEIH","SH","NDX",".DJI","TQQQ","YSPY","DDM","TBFG","03455","VOO","TQQY","ITDJ","ITDI","MVFG","QMAR","LEXI","SPXS","SQQQ","DXD","SDOW","09086","XBI","MMAX","RNMN","BK4588","QALT","03034","159837","DIA","PCPP","07266","LNGR","MEDX","QPX","GAA","BK4585","09834","DMAX","QQQM","07261","NTSI","SPYU","TRIO","EUCG","NJAN","WISE","QQQ","07522","SPYQ","WLTG","ARP","GPIQ","KNOW","NOCT","161715","WDAI","NDAA","SPDN","GDOC","SPXU",".SPX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2660210540","title":"全球资产配置进入“去拥挤化”时刻! 美银从AI算力转向价值、生物科技与大宗商品 寻找“非共识阿尔法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2660210540","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660210540?lang=zh_cn&edition=full","pubTime":"2026-08-17 08:45","pubTimestamp":1786927514,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["WLTG","GAA","ARP","XBI","BTR","ITDI","LNGR","GAL","BK4588","BK4581","FPAA","QPX","RNMN","PCPP","TBFG","TRIO","WDAI","AGNG","DRAI","ITDJ","GMOM","KNOW","KOOL","SYNB","NTSI","GDMA","AIO","BK4585","WISE","QALT","AGOX","GDOC","IBBJ","EUCG","NMBL","IEIH","ITDF","TCTL","AVMA","LEXI","NDAA","DDX","MEDX","EEV","MVFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654093215","title":"就在今天｜“宏观关键拐点，资产何去何从？”国泰海通宏观与全球资产配置沙龙·北京站","url":"https://stock-news.laohu8.com/highlight/detail?id=2654093215","media":"国泰君安证券研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654093215?lang=zh_cn&edition=full","pubTime":"2026-07-27 06:16","pubTimestamp":1785104160,"startTime":"0","endTime":"0","summary":"更多国泰海通研究和服务亦可联系对口销售获取重要提醒本订阅号所载内容仅面向国泰海通证券研究服务签约客户。因本资料暂时无法设置访问限制，根据《证券期货投资者适当性管理办法》的要求，若您并非国泰海通证券研究服务签约客户，为保证服务质量、控制投资风险，还请取消关注，请勿订阅、接收或使用本订阅号中的任何信息。法律声明本公众订阅号为国泰海通证券股份有限公司 研究所依法设立、独立运营的唯一官方订阅号。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["research"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA5MzEwMDEzNQ==&mid=2650539925&idx=1&sn=ad4e26ed0f86e8953ee0ec39876db951&chksm=89fc20b907a4c84362e029fad3dd968f8ca416663f92903c7e7907e5856204d44ae7755c0279&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["WLTG","AGOX","MVFG","BK0028","NMBL","DDX","PCPP","ITDI","ITDF","NTSI","TBFG","BK1564","EUCG","BK0183","BK0184","ITDJ","BK0188","TCTL","BTR","BK0201","GAL","BK1147","NDAA","RNMN","601211","GAA","DRAI","QPX","QALT","02611","ARP","BK0012","KNOW","FPAA","BK0276","TRIO","GDMA","LEXI","GMOM","KOOL","AVMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649698469","title":"富达国际刘闵悦：中国是全球资产配置重要组成部分","url":"https://stock-news.laohu8.com/highlight/detail?id=2649698469","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649698469?lang=zh_cn&edition=full","pubTime":"2026-07-07 19:11","pubTimestamp":1783422715,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2242644610.SGD","IE00B12V2V27.USD","ITDF","LU0455707207.USD","TBFG","BK4539","BK4022","DDX","DRAI","IE00BYTNYN87.SGD","ITDI","QPX","LU0048575426.USD","WLTG","LU1023057109.AUD","GMOM","LEXI","LU0359201885.HKD","NDAA","BK4232","LU0572944931.SGD","LU0327786744.USD","ITDJ","YMM","LU2247934214.USD","NTSI","LU0261950470.USD","BK4503","SG9999011746.SGD","ARP","MVFG","LU0502904849.HKD","BK4526","AGOX","GAA","GDMA","LU0456842615.SGD","KNOW","AVMA","LU0359202008.SGD","LU0251143458.SGD","BTR","IE00BYQNZ168.SGD","KOOL","LU0359201612.USD","BK4548","GAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495054976","title":"2024药企出海：做难而正确的事","url":"https://stock-news.laohu8.com/highlight/detail?id=2495054976","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495054976?lang=zh_cn&edition=full","pubTime":"2024-12-30 20:41","pubTimestamp":1735562466,"startTime":"0","endTime":"0","summary":"2024年，出海依然是生物医药产业的关键词。ADC、双抗药物合作交易火爆，出海数量再创新高；交易金额上限不断突破，多家药企凭借出海扭亏为盈。海外市场为生物医药产业带来了新的增量和发展方向，但走好出海之路绝非易事。近年来，创新药海外合作数量上升的同时，也有部分合作半路终止。此外，还有企业受地缘政治等因素影响，割舍或是调整海外业务。不过，好在各方都没有放弃，而是积极探索出新的道路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412303282962268.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412303282962268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09939","BK4007","BK4532","02162","BK1515","BK4585","BK4588","BK4080","BK1583","PML","BK1587","NDAA","GSK.UK","BK1161","BK1574","ADC","GSK","BMS","LU1829250122.USD","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493727494","title":"近9000亿美元军费支出 拜登签署2025财年国防授权法案","url":"https://stock-news.laohu8.com/highlight/detail?id=2493727494","media":"环球时报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493727494?lang=zh_cn&edition=full","pubTime":"2024-12-24 13:51","pubTimestamp":1735019460,"startTime":"0","endTime":"0","summary":"当地时间23日，美国总统拜登签署2025财年国防授权法案，将美国军费支出提升至约8950亿美元，较上一财年增长1%。2025财年国防授权法案将提升现役军人工资，增加在亚太的军事支出，并授权美军与以色列军队拓展联合军事演习等。桑德斯认为，美国的国防体系已成为少数大型国防承包商牟利的工具，而不是服务于国家需要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-24/doc-ineapwes8469507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NDAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490071840","title":"美全面禁止从科技到大蒜等中国商品 法案充斥着同中国对抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2490071840","media":"映象网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490071840?lang=zh_cn&edition=full","pubTime":"2024-12-12 11:19","pubTimestamp":1733973540,"startTime":"0","endTime":"0","summary":"从激光导航技术到大蒜，美国国会众议院已经通过了一项包含禁止诸多中国进口商品的法案，并极有可能在今年年底成为正式法律。报道指出，“国防授权法案”为美国国防部设定了最高预算并指导政策方向，可谓是一项“必须通过”的法案，因为该法案的颁布是军人按时领取薪资和福利的必要条件。而与往年一样，2025财年的“国防授权法案”充斥着“同中国竞争和对抗”的相关内容。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-12/doc-inczekkt3179903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NDAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490845309","title":"美国众议院通过2025财年“国防授权法案”，全面禁止进口从激光雷达到大蒜等中国商品","url":"https://stock-news.laohu8.com/highlight/detail?id=2490845309","media":"观察者网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490845309?lang=zh_cn&edition=full","pubTime":"2024-12-12 09:07","pubTimestamp":1733965620,"startTime":"0","endTime":"0","summary":"而与往年一样，2025财年的“国防授权法案”充斥着“同中国竞争和对抗”的相关内容。去年12月，美国总统拜登曾将“2024财年国防授权法案”签署成法，该法案包含涉华消极条款。对此，中国外交部发言人毛宁回应指出，美方执意通过并签署包含涉华消极内容的“2024财年国防授权法案”，中方对此表示强烈不满和坚决反对，已向美方提出严正交涉。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-12/doc-inczeeax0016643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FDD","BK4024","AEI","NDAA","BK4563","BK4582"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490301723","title":"《生物安全法案》“搭便车”NDAA失败，国内CXO板块迎反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=2490301723","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490301723?lang=zh_cn&edition=full","pubTime":"2024-12-09 19:22","pubTimestamp":1733743341,"startTime":"0","endTime":"0","summary":"每经记者：许立波&nbsp;&nbsp;&nbsp;&nbsp;每经编辑：杨夏当地时间12月7日，美国国会参众两院军事委员会公布了2025财年国防授权法案（以下简称“NDAA”）最终协议文本，该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示，《生物安全法案》未被列入其中，意味着《生物安全法案》通过“夹带”进NDAA进而实现立法的...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OVeLbzmbNy8zvfEv4R_rJMi0rf7KWPkL8gZp0PEHwB5W4AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OVeLbzmbNy8zvfEv4R_rJMi0rf7KWPkL8gZp0PEHwB5W4AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241209A08E2000","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241209A08E2000","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["CXO","NDAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490710665","title":"药明系迎大利好！下一个催化剂是？","url":"https://stock-news.laohu8.com/highlight/detail?id=2490710665","media":"金十数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490710665?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:16","pubTimestamp":1733732183,"startTime":"0","endTime":"0","summary":"周末消息称，美国生物安全法案未被纳入NDAA，多家机构表示，这可能是国内医药板块的关键节点。","market":"hk","thumbnail":"https://img.jin10.com/news/24/12/Qzge3Cc2IR7IBRzKIVp1Z.png/lite","type":0,"news_type":0,"thumbnails":["https://img.jin10.com/news/24/12/Qzge3Cc2IR7IBRzKIVp1Z.png/lite"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://xnews.jin10.com/webapp/details.html?id=155494&type=news&data_type=0","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"xnew_highlight","symbols":["NDAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490146827","title":"【A股收评】三大指数震荡调整，机器人概念卷土重来！","url":"https://stock-news.laohu8.com/highlight/detail?id=2490146827","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490146827?lang=zh_cn&edition=full","pubTime":"2024-12-09 15:22","pubTimestamp":1733728930,"startTime":"0","endTime":"0","summary":"12月9日，三大指数集体调整，截至收盘，沪指跌0.05%，深成指跌0.55%，创业板跌0.81%，科创50指数跌1.09%，两市超2000只个股上涨，沪深两市今日成交额约1.63万亿元。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202412_1/752e3c68-7dfe-4a74-b97c-1a04beb480c3.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202412_1/752e3c68-7dfe-4a74-b97c-1a04beb480c3.png"],"rights":{"source":"finet_stock","url":"https://www.finet.hk/newscenter/news_content/67569aa253243c0b5baf20c0","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/67569aa253243c0b5baf20c0","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["NDAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490718823","title":"美生物安全法案“生变”，CRO概念大举反攻，药明系嗨了！","url":"https://stock-news.laohu8.com/highlight/detail?id=2490718823","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490718823?lang=zh_cn&edition=full","pubTime":"2024-12-09 12:10","pubTimestamp":1733717419,"startTime":"0","endTime":"0","summary":"行业悲观预期或好转","market":"us","thumbnail":"https://img3.gelonghui.com/25d53-cb9c4747-fd5c-4169-a43e-056e33d68b09.jpg?guru_height=718&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/25d53-cb9c4747-fd5c-4169-a43e-056e33d68b09.jpg?guru_height=718&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1449943","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1576","LU0320764599.SGD","300149","BK0077","BK0086","LU0348735423.USD","BK0081","BK1141","LU0348825331.USD","BK1521","LU0819121731.USD","SG9999014674.SGD","301201","LU0043850808.USD","LU0516422366.SGD","LU0051755006.USD","LU0456846285.SGD","LU1997245177.USD","LU1880383366.USD","LU2045819591.USD","LU0856984785.SGD","LU0359202008.SGD","LU0052750758.USD","LU0456842615.SGD","BK0102","LU0823426308.USD","BK0042","BK0216","BK1583","LU1794554557.SGD","SG9999002562.SGD","NDAA","000710","LU1046422090.SGD","LU0823426480.USD","02268","02359","LU0307460666.USD","LU1242518931.SGD","LU0327786744.USD","LU0572944931.SGD","LU1688375341.USD","LU2039709279.SGD","LU2488822045.USD","603259","LU2242644610.SGD","LU0359201612.USD","LU0456827905.SGD","BK0028"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2490959507","title":"美生物安全法案未纳入NDAA，CXO巨头药明康德飙升逾7.5%！医疗ETF（512170）涨超1%冲击三连阳","url":"https://stock-news.laohu8.com/highlight/detail?id=2490959507","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490959507?lang=zh_cn&edition=full","pubTime":"2024-12-09 10:49","pubTimestamp":1733712540,"startTime":"0","endTime":"0","summary":"海外利空解除，9日早盘，巨头药明康德跳空高开逾8%后维持高位，现涨超7.5%，领涨50只中证医疗成份股！九州药业、凯莱英、康龙化成等CXO概念股纷纷跟涨。　　267亿体量顶流医疗ETF高开近2%，现涨逾1%。　　消息面上，美国当地时间2024年12月7日，美国国会参众两院军事委员会公布了2025财年国防授权法案最终协议文本，该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示，生物安全法案未被列入其中。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2024-12-09/doc-incyvnxt2953829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02359","BK1583","LU0052750758.USD","LU0320764599.SGD","NDAA","BK1576","LU1997245094.SGD","BK0216","512170","LU0708995583.HKD","BK1141","603259","LU2045819591.USD","LU0456842615.SGD","LU2242644610.SGD","LU1046422090.SGD","LU2125910500.SGD","159828","CXO","LU1997245177.USD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490901767","title":"港股概念追踪|生物安全法案未被列入NDAA最新版本   机构看好CXO板块底部机会（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2490901767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490901767?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:29","pubTimestamp":1733707775,"startTime":"0","endTime":"0","summary":"美国当地时间2024年12月7日，美国国会参众两院军事委员会公布了2025财年国防授权法案最终协议文本，该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示，生物安全法案未被列入其中。当地时间12月5日， 专注于生物制药行业的美国新闻媒体Endpoints报道，消息人士称，立法者正在考虑对针对生物安全法案的立法进行妥协，该立法将增加行政部门的审查，而不是直接禁止生物制药公司与中国公司合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02269","LU1242518931.SGD","LU0043850808.USD","LU0359202008.SGD","HSTECH","LU1794554557.SGD","LU2039709279.SGD","LU2125910500.SGD","LU0359201612.USD","LU0181495838.USD","LU1720050803.USD","LU0516422440.USD","06821","07226","LU0052750758.USD","LU1880383366.USD","NDAA","LU2045819591.USD","LU0348825331.USD","LU0823426480.USD","LU0708995583.HKD","LU0516423091.SGD","LU0979878070.USD","LU0417516738.SGD","LU1242518857.USD","CXO","LU0140636845.USD","LU0516422366.SGD","LU0417516902.SGD","BK1191","BK1589","LU0456827905.SGD","HSCEI","YANG","LU0572944931.SGD","LU0856984785.SGD","LU1046422090.SGD","LU0516423174.USD","BK1576","BK1583","LU0348735423.USD","LU0588546209.SGD","BK1521","LU0039217434.USD","BK1141","BK1610","02359","LU0307460666.USD","LU2242644610.SGD","LU0051755006.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2490762502","title":"港股异动 | CRO概念股集体高开 生物安全法案未被列入美参众两院最终版NDAA","url":"https://stock-news.laohu8.com/highlight/detail?id=2490762502","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490762502?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:23","pubTimestamp":1733707405,"startTime":"0","endTime":"0","summary":"消息面上，当地时间12月7日，美国国会参众两院军事委员会公布了2025财年国防授权法案最终协议文本，该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示，生物安全法案未被列入其中。按照流程，该版本要获得美国总统签字之后才能生效。招银国国际认为，这意味着生物安全法案试图通过加入NDAA的立法路径失败。生物安全法案仍可以推进单独立法，但考虑到仅剩两周窗口期，该行认为单独立法的成功率极低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221928.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1046422090.SGD","LU0359201612.USD","LU0348825331.USD","LU0572944931.SGD","LU0052750758.USD","LU0456846285.SGD","LU0856984785.SGD","LU2125910500.SGD","06127","LU0516422366.SGD","HK0000306701.USD","HK0000306685.HKD","LU1794554557.SGD","SG9999002463.SGD","LU0823426308.USD","LU0708995583.HKD","LU0039217434.USD","03759","LU0823426480.USD","LU2045819591.USD","BK1610","HK0000320264.USD","LU1688375341.USD","LU0327786744.USD","HK0000320223.HKD","02269","LU0417516902.SGD","LU0516423091.SGD","LU1242518931.SGD","LU1720050803.USD","BK1589","LU0516423174.USD","LU0979878070.USD","BK1141","LU0516422952.EUR","LU0140636845.USD","LU0348735423.USD","LU0307460666.USD","LU0181495838.USD","LU0588546209.SGD","LU0516422440.USD","NDAA","01548","IE00B0JY6N72.USD","LU0320764599.SGD","LU2242644610.SGD","LU0417516738.SGD","02359","BK1583","BK1521"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2490968798","title":"美国防法案未纳入生物安全“黑名单”，美媒：意味着与中国有关的公司获得喘息之机","url":"https://stock-news.laohu8.com/highlight/detail?id=2490968798","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490968798?lang=zh_cn&edition=full","pubTime":"2024-12-09 06:36","pubTimestamp":1733697360,"startTime":"0","endTime":"0","summary":"7日，美国国会参众两院军事委员会公布了年度国防授权法案最终协议文本，《生物安全法案》未被列入其中。彭博社7日称，这意味着与中国有关联的生物技术公司暂时不会被列入禁止签订合同的黑名单中，这让这些公司获得了喘息之机。《生物安全法案》将影响5家中资企业，包括药明康德等生物科技企业。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-09/doc-incyvakc6272988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NDAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489738003","title":"短线要防“假突破”，交易面盯紧三个变量！","url":"https://stock-news.laohu8.com/highlight/detail?id=2489738003","media":"钱眼","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2489738003?lang=zh_cn&edition=full","pubTime":"2024-12-08 19:09","pubTimestamp":1733656140,"startTime":"0","endTime":"0","summary":"NDAA最新版本显示，生物安全法案未被列入其中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2024-12-08/doc-incytywr6842943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NDAA","159982"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0.0223},{"period":"3month","weight":0.026},{"period":"6month","weight":0.0808},{"period":"1year","weight":0.1904},{"period":"ytd","weight":0.1232}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"NASDAQ","name":"NED Davis Research 360 Dynamic Allocation Etf","nameEN":"NED Davis Research 360 Dynamic Allocation Etf"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NED Davis Research 360 Dynamic Allocation Etf(NDAA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NED Davis Research 360 Dynamic Allocation Etf(NDAA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NED Davis Research 360 Dynamic Allocation Etf,NDAA,NED Davis Research 360 Dynamic Allocation Etf股票,NED Davis Research 360 Dynamic Allocation Etf股票老虎,NED Davis Research 360 Dynamic Allocation Etf股票老虎国际,NED Davis Research 360 Dynamic Allocation Etf行情,NED Davis Research 360 Dynamic Allocation Etf股票行情,NED Davis Research 360 Dynamic Allocation Etf股价,NED Davis Research 360 Dynamic Allocation Etf股市,NED Davis Research 360 Dynamic Allocation Etf股票价格,NED Davis Research 360 Dynamic Allocation Etf股票交易,NED Davis Research 360 Dynamic Allocation Etf股票购买,NED Davis Research 360 Dynamic Allocation Etf股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NED Davis Research 360 Dynamic Allocation Etf(NDAA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NED Davis Research 360 Dynamic Allocation Etf(NDAA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}